World Migraine Market to See Modest Growth in the Offing, States Koncept Analytics in Its Topical Report Published at MarketPublishers.com
09 Jun 2016 • by Natalie Aster
LONDON – Triptans and ergot alkaloids are amid the most popular medication options existing in the migraine treatment marketplace. Currently facing a number of unmet needs, the worldwide migraine treatment market has reached saturation with a slew of generic drugs available. A number of branded drug products are in the pipeline with more effective and safer profiles, given a plethora of opportunities being opened up in the marketplace. The focus of forthcoming drugs is to either cure migraine headaches or to minimise the frequency to a degree where patients can search out tolerable relief.
The migraine market is poised to register a modest growth rate in the offing, fuelled by the launch of novel therapies and surging rate of drug treatments owing to the rising awareness amongst patients and physicians and the growing female population. The major factors driving the migraine market growth encompass increasing spending on medicinal products, expanding female population, soaring cigarette consumption and healthcare spending. Nevertheless, the complications associated with triptans, limitations of medical treatment amid patients with cardiovascular risk factors as well as the rising preference for OTC medications could pose a challenge to the market growth.
Topical report “Global Migraine Market Report: 2016 Edition” elaborated by Koncept Analytics is devoted to an in-depth analysis of the present-day status of the market in tandem with its potential future development. The market of the USA is carefully discussed in the research report. Furthermore, the study casts light on the major trends, growth drivers and issues with respect to the industry. It also includes granular profiles of the major players in the industry, along with an analysis of their key financials and growth strategies.
More cutting-edge market studies by the publisher can be found at Koncept Analytics page.